IP Library Granted Patent US 8,414,916
Granted Patent B2
US 8,414,916 · App. 13/491,670 · Granted Apr 9, 2013

Chewable soft capsule

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,414,916
App. No.
13/491,670
Granted
Apr 9, 2013
Kind
B2
Abstract

A matrix formulation for a soft chewable capsule is provided which includes a gel-forming composition, a plasticizer, a polymer modifier, and water. The polymer modifier may be a carboxylic acid or other organic compound that alters the physical and/or chemical properties of the capsule formulation. A chewable soft capsule is also provided, having enhanced organo-leptic and processing properties. An active material may be delivered to a user using this dosage form. A method of forming the chewable soft capsule is also provided.

Claims (28)

1. A chewable soft capsule suitable for chewing comprising a matrix comprising:

at least a first gel-forming composition comprising carbohydrates, carbopolymers, polysaccharides, starch, modified starch, alginates, hydroxylpropylmethyl cellulose, methyl cellulose, or combinations thereof;

at least a first plasticizer; and

water; and

a sheath that encapsulates the matrix and comprises:

at least a second gel-forming composition comprising gelatin, partially hydrolyzed gelatin, hydrolyzed gelatin, carbohydrates, carbopolymers, polysaccharides, starch, modified starch, alginates, hydroxylpropylmethyl cellulose, methyl cellulose, or combinations thereof;

at least a second plasticizer;

at least one polymer modifier (a) selected from the group consisting of mono, di, or poly carboxylic acids, salts thereof, and combinations thereof; or (b) that comprises at least two carboxylic acids selected from the group consisting of lactic acid, fumaric acid, tartaric acid, citric acid, glycolic acid, salts thereof, and buffers thereof; and

water.

2. The chewable soft capsule of claim 1 , wherein the first gel-forming composition comprises 20% to about 80% of the matrix by weight.

3. The chewable soft capsule of claim 1 , wherein the second gel-forming composition comprises 5% to about 25% of the sheath by weight.

4. The chewable soft capsule of claim 1 , wherein the first gel forming composition exhibits a bloom in the range of about 0 to 80.

5. The chewable soft capsule of claim 1 , wherein the first gel forming composition exhibits a bloom in the range of about 60 to about 80.

6. The chewable soft capsule of claim 1 , wherein the second gel forming composition exhibits a bloom in the range of about 80 to about 250.

7. The chewable soft capsule of claim 1 , wherein the second gel forming composition exhibits a bloom in the range of about 100 to about 175.

8. The chewable soft capsule of claim 1 , wherein the first and second plasticizers are selected from the group consisting of glycerol, sorbitol, maltito xylitol, and combinations thereof.

9. The chewable soft capsule of claim 1 , wherein the first plasticizer comprises from about 10% to about 40% of the matrix by weight.

10. The chewable soft capsule of claim 1 , wherein the first plasticizer comprises from about 10% to about 30% of the matrix by weight.

11. The chewable soft capsule of claim 1 , wherein the second plasticizer comprises from about 5% to about 40% of the sheath by weight.

12. The chewable soft capsule of claim 1 , wherein the second plasticizer comprises from about 10% to about 30% of the sheath by weight.

13. The chewable soft capsule of claim 1 , wherein the polymer modifier is citric acid.

14. The chewable soft capsule of claim 1 , wherein the polymer modifier comprises from about 0.5-10% of the sheath by weight.

15. The chewable soft capsule of claim 1 , wherein the matrix comprises water from about 5% to about 30% of the matrix by weight.

16. The chewable soft capsule of claim 1 , wherein the matrix comprises water from about 5% to about 15% of the matrix by weight.

17. The chewable soft capsule of claim 1 wherein the sheath comprises water from about 5% to about 40% of the sheath by weight.

18. The chewable soft capsule of claim 1 , wherein the sheath comprises water from about 5% to about 15% of the sheath by weight.

19. The chewable soft capsule of claim 1 , further comprising an active ingredient.

20. The chewable soft capsule of claim 19 , wherein the active ingredient is selected from the group consisting, of NTHEs, analgesics, antihistaminics, anti-asthmatics, anti-epileptics, antibiotics, decongestants, anti-allergenics, and food supplements.

Assignments (10)
RELEASE (REEL 032403 / FRAME 0790) Recorded Sep 28, 2017
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BANNER PHARMACAPS INC.
Reel/Frame 044038/0028 →
NOTICE OF SUCCESSION OF AGENCY FOR PATENT SECURITY INTEREST PREVIOUSLY RECORDED AT REEL/FRAME (032403/0790) Recorded Jul 12, 2017
From: UBS AG, STAMFORD BRANCH, AS PRIOR AGENT
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS SUCCESSOR AGENT
Reel/Frame 043173/0005 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 29, 2017
From: BANNER LIFE SCIENCES LLC
To: PATHEON SOFTGELS INC
Reel/Frame 043032/0619 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2015
From: UBS AG, STAMFORD BRANCH
To: BANNER LIFE SCIENCES LLC; BANNER PHARMACAPS INC.
Reel/Frame 036224/0623 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2015
From: UBS AG, STAMFORD BRANCH
To: BANNER LIFE SCIENCES LLC
Reel/Frame 036239/0188 →
SECURITY INTEREST Recorded Mar 5, 2015
From: BANNER LIFE SCIENCES LLC
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 035133/0328 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 19, 2014
From: BANNER PHARMACAPS INC
To: BANNER LIFE SCIENCES LLC
Reel/Frame 034294/0916 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS Recorded Apr 23, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: BANNER PHARMACAPS INC.
Reel/Frame 032745/0454 →
SECURITY INTEREST Recorded Mar 11, 2014
From: BANNER PHARMACAPS INC.
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 032403/0790 →
SECURITY AGREEMENT Recorded Dec 17, 2012
From: BANNER PHARMACAPS INC.
To: MORGAN STANLEY SENIOR FUNDING INC., AS COLLATERAL AGENT
Reel/Frame 029481/0962 →